{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,13]],"date-time":"2026-07-13T22:02:53Z","timestamp":1783980173378,"version":"3.55.0"},"reference-count":54,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2017,11,20]],"date-time":"2017-11-20T00:00:00Z","timestamp":1511136000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"name":"University Malaya High Impact Research Grant","award":["H-20001-E000091"],"award-info":[{"award-number":["H-20001-E000091"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Osteoporos Int"],"published-print":{"date-parts":[[2018,3]]},"DOI":"10.1007\/s00198-017-4305-8","type":"journal-article","created":{"date-parts":[[2017,11,20]],"date-time":"2017-11-20T14:45:07Z","timestamp":1511189107000},"page":"595-613","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":53,"title":["Reduced bone mineral density in human immunodeficiency virus-infected individuals: a meta-analysis of its prevalence and risk factors"],"prefix":"10.1007","volume":"29","author":[{"given":"S. S. L.","family":"Goh","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P. S. M.","family":"Lai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A. T. B.","family":"Tan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Ponnampalavanar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,11,20]]},"reference":[{"issue":"5","key":"4305_CR1","doi-asserted-by":"publisher","first-page":"617","DOI":"10.1097\/QAD.0b013e3280148c05","volume":"21","author":"JH Arnsten","year":"2007","unstructured":"Arnsten JH, Freeman R, Howard AA, Floris-Moore M, Lo Y, Klein RS (2007) Decreased bone mineral density and increased fracture risk in aging men with or at risk for HIV infection. AIDS 21(5):617\u2013623. \nhttps:\/\/doi.org\/10.1097\/QAD.0b013e3280148c05","journal-title":"AIDS"},{"issue":"2","key":"4305_CR2","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1310\/hct1102-100","volume":"11","author":"NF Onen","year":"2010","unstructured":"Onen NF et al (2010) Aging and HIV infection: a comparison between older HIV-infected persons and the general population. HIV Clin Trials 11(2):100\u2013109. \nhttps:\/\/doi.org\/10.1310\/hct1102-100","journal-title":"HIV Clin Trials"},{"issue":"8","key":"4305_CR3","doi-asserted-by":"publisher","first-page":"937","DOI":"10.1086\/656412","volume":"51","author":"GA McComsey","year":"2010","unstructured":"McComsey GA, Tebas P, Shane E, Yin MT, Overton ET, Huang JS, Aldrovandi GM, Cardoso SW, Santana JL, Brown TT (2010) Bone disease in HIV infection: a practical review and recommendations for HIV care providers. Clin Infect Dis 51(8):937\u2013946. \nhttps:\/\/doi.org\/10.1086\/656412","journal-title":"Clin Infect Dis"},{"issue":"17","key":"4305_CR4","doi-asserted-by":"publisher","first-page":"2165","DOI":"10.1097\/QAD.0b013e32801022eb","volume":"20","author":"TT Brown","year":"2006","unstructured":"Brown TT, Qaqish RB (2006) Antiretroviral therapy and the prevalence of osteopenia and osteoporosis: a meta-analytic review. AIDS 20(17):2165\u20132174. \nhttps:\/\/doi.org\/10.1097\/QAD.0b013e32801022eb","journal-title":"AIDS"},{"key":"4305_CR5","unstructured":"Foundation, N.O. Bone density exam or testing. 2017; Available from: https:\/\/www.nof.org\/patients\/diagnosis-information\/bone-density-examtesting\/"},{"issue":"14","key":"4305_CR6","doi-asserted-by":"publisher","first-page":"2119","DOI":"10.1097\/QAD.0000000000000363","volume":"28","author":"HV Dong","year":"2014","unstructured":"Dong HV, Cort\u00e9s YI, Shiau S, Yin MT (2014) Osteoporosis and fractures in HIV\/hepatitis C virus coinfection: a systematic review and meta-analysis. AIDS 28(14):2119\u20132131. \nhttps:\/\/doi.org\/10.1097\/QAD.0000000000000363","journal-title":"AIDS"},{"key":"4305_CR7","unstructured":"National Institutes of Health, Quality assessment tool for observational cohort and cross-sectional studies National Institutes of Health, 2014"},{"issue":"3 Suppl","key":"4305_CR8","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/S0749-3797(01)00261-6","volume":"20","author":"RP Harris","year":"2001","unstructured":"Harris RP, Helfand M, Woolf SH, Lohr KN, Mulrow CD, Teutsch SM, Atkins D (2001) Current methods of the US Preventive Services Task Force: a review of the process. Am J Prev Med 20(3 Suppl):21\u201335. \nhttps:\/\/doi.org\/10.1016\/S0749-3797(01)00261-6","journal-title":"Am J Prev Med"},{"issue":"3","key":"4305_CR9","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1359\/JBMR.0301246","volume":"19","author":"C Amiel","year":"2004","unstructured":"Amiel C, Ostertag A, Slama L, Baudoin C, N'Guyen T, Lajeunie E, Neit-Ngeilh L, Rozenbaum W, de Vernejoul MC (2004) BMD is reduced in HIV-infected men irrespective of treatment. J Bone Miner Res 19(3):402\u2013409. \nhttps:\/\/doi.org\/10.1359\/JBMR.0301246","journal-title":"J Bone Miner Res"},{"issue":"7","key":"4305_CR10","doi-asserted-by":"publisher","first-page":"1014","DOI":"10.1086\/501015","volume":"42","author":"JH Arnsten","year":"2006","unstructured":"Arnsten JH, Freeman R, Howard AA, Floris-Moore M, Santoro N, Schoenbaum EE (2006) HIV infection and bone mineral density in middle-aged women. Clin Infect Dis 42(7):1014\u20131020. \nhttps:\/\/doi.org\/10.1086\/501015","journal-title":"Clin Infect Dis"},{"issue":"2","key":"4305_CR11","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1111\/j.1365-2265.2006.02572.x","volume":"65","author":"MJ Bolland","year":"2006","unstructured":"Bolland MJ, Grey AB, Horne AM, Briggs SE, Thomas MG, Ellis-Pegler RB, Woodhouse AF, Gamble GD, Reid IR (2006) Bone mineral density is not reduced in HIV-infected Caucasian men treated with highly active antiretroviral therapy. Clin Endocrinol 65(2):191\u2013197. \nhttps:\/\/doi.org\/10.1111\/j.1365-2265.2006.02572.x","journal-title":"Clin Endocrinol"},{"issue":"3","key":"4305_CR12","doi-asserted-by":"publisher","first-page":"1200","DOI":"10.1210\/jc.2003-031506","volume":"89","author":"TT Brown","year":"2004","unstructured":"Brown TT, Ruppe MD, Kassner R, Kumar P, Kehoe T, Dobs AS, Timpone J (2004) Reduced bone mineral density in human immunodeficiency virus-infected patients and its association with increased central adiposity and postload hyperglycemia. J Clinical Endocrinology Metabolism 89(3):1200\u20131206. \nhttps:\/\/doi.org\/10.1210\/jc.2003-031506","journal-title":"J Clinical Endocrinology Metabolism"},{"issue":"13","key":"4305_CR13","doi-asserted-by":"publisher","first-page":"1917","DOI":"10.1097\/00002030-200309050-00010","volume":"17","author":"D Bruera","year":"2003","unstructured":"Bruera D, Luna N, David DO, Bergoglio LM, Zamudio J (2003) Decreased bone mineral density in HIV-infected patients is independent of antiretroviral therapy. AIDS 17(13):1917\u20131923. \nhttps:\/\/doi.org\/10.1097\/00002030-200309050-00010","journal-title":"AIDS"},{"issue":"3","key":"4305_CR14","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1097\/00002030-200402200-00014","volume":"18","author":"SE Dolan","year":"2004","unstructured":"Dolan SE, Huang JS, Killilea KM, Sullivan MP, Aliabadi N, Grinspoon S (2004) Reduced bone density in HIV-infected women. AIDS 18(3):475\u2013483. \nhttps:\/\/doi.org\/10.1097\/00002030-200402200-00014","journal-title":"AIDS"},{"issue":"3","key":"4305_CR15","doi-asserted-by":"publisher","first-page":"386","DOI":"10.1093\/infdis\/jis687","volume":"207","author":"ML Grijsen","year":"2013","unstructured":"Grijsen ML, Vrouenraets SME, Wit FWNM, Stolte IG, Prins M, Lips P, Reiss P, Prins JM (2013) Low bone mineral density, regardless of HIV status, in men who have sex with men. J Infect Dis 207(3):386\u2013391. \nhttps:\/\/doi.org\/10.1093\/infdis\/jis687","journal-title":"J Infect Dis"},{"issue":"7","key":"4305_CR16","doi-asserted-by":"publisher","first-page":"913","DOI":"10.1007\/s00198-007-0524-8","volume":"19","author":"S Jones","year":"2008","unstructured":"Jones S, Restrepo D, Kasowitz A, Korenstein D, Wallenstein S, Schneider A, Keller MJ (2008) Risk factors for decreased bone density and effects of HIV on bone in the elderly. Osteoporos Int 19(7):913\u2013918. \nhttps:\/\/doi.org\/10.1007\/s00198-007-0524-8","journal-title":"Osteoporos Int"},{"issue":"5","key":"4305_CR17","doi-asserted-by":"publisher","first-page":"482","DOI":"10.1016\/S1297-319X(02)00433-5","volume":"69","author":"S Loiseau-P\u00e9r\u00e8s","year":"2002","unstructured":"Loiseau-P\u00e9r\u00e8s S, Delaunay C, Poupon S, Lespessailles E, Ballouche N, Arsac P, Benhamou CL (2002) Osteopenia in patients infected by the human immunodeficiency virus. A case control study. Joint Bone Spine 69(5):482\u2013485. \nhttps:\/\/doi.org\/10.1016\/S1297-319X(02)00433-5","journal-title":"Joint Bone Spine"},{"issue":"1","key":"4305_CR18","first-page":"39","volume":"48","author":"G Madeddu","year":"2004","unstructured":"Madeddu G, Spanu A, Solinas P, Calia GM, Lovigu C, Chessa F, Mannazzu M, Falchi A, Mura MS, Madeddu G (2004) Bone mass loss and vitamin D metabolism impairment in HIV patients receiving highly active antiretroviral therapy. Quarterly J Nuclear Medicine Molecular Imaging 48(1):39\u201348","journal-title":"Quarterly J Nuclear Medicine Molecular Imaging"},{"issue":"2","key":"4305_CR19","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1097\/01.qai.0000435598.20104.d6","volume":"65","author":"E Negredo","year":"2014","unstructured":"Negredo E, Domingo P, Ferrer E, Estrada V, Curran A, Navarro A, Isernia V, Rosales J, P\u00e9rez-\u00c1lvarez N, Puig J, Bonjoch A, Echeverr\u00eda P, Podzamczer D, Clotet B (2014) Peak bone mass in young HIV-infected patients compared with healthy controls. Jaids-J Acquired Immune Deficiency Syndromes 65(2):207\u2013212. \nhttps:\/\/doi.org\/10.1097\/01.qai.0000435598.20104.d6","journal-title":"Jaids-J Acquired Immune Deficiency Syndromes"},{"issue":"4","key":"4305_CR20","doi-asserted-by":"publisher","first-page":"F63","DOI":"10.1097\/00002030-200003100-00005","volume":"14","author":"P Tebas","year":"2000","unstructured":"Tebas P, Powderly WG, Claxton S, Marin D, Tantisiriwat W, Teitelbaum SL, Yarasheski KE (2000) Accelerated bone mineral loss in HIV-infected patients receiving potent antiretroviral therapy. AIDS 14(4):F63\u2013F67. \nhttps:\/\/doi.org\/10.1097\/00002030-200003100-00005","journal-title":"AIDS"},{"issue":"4","key":"4305_CR21","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1053\/jinf.2002.1109","volume":"46","author":"J Teichmann","year":"2003","unstructured":"Teichmann J, Stephan E, Lange U, Discher T, Friese G, Lohmeyer J, Stracke H, Bretzel RG (2003) Osteopenia in HIV-infected women prior to highly active antiretroviral therapy. J Infect 46(4):221\u2013227. \nhttps:\/\/doi.org\/10.1053\/jinf.2002.1109","journal-title":"J Infect"},{"issue":"2","key":"4305_CR22","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1186\/2047-783X-14-2-59","volume":"14","author":"J Teichmann","year":"2009","unstructured":"Teichmann J, Lange U, Discher T, Lohmeyer J, Stracke H, Bretzel RG (2009) Bone mineral density in human immunodeficiency virus-1 infected men with hypogonadism prior to highly-active-antiretroviral-therapy (HAART). Eur J Med Res 14(2):59\u201364. \nhttps:\/\/doi.org\/10.1186\/2047-783X-14-2-59","journal-title":"Eur J Med Res"},{"issue":"6","key":"4305_CR23","doi-asserted-by":"publisher","first-page":"707","DOI":"10.1016\/j.bjid.2013.05.009","volume":"17","author":"OA Ayd\u0131n","year":"2013","unstructured":"Ayd\u0131n OA, Karaosmanoglu HK, Karahasanoglu R, Tahmaz M, Nazl\u0131can O (2013) Prevalence and risk factors of osteopenia\/osteoporosis in Turkish HIV\/AIDS patients. Braz J Infect Dis 17(6):707\u2013711. \nhttps:\/\/doi.org\/10.1016\/j.bjid.2013.05.009","journal-title":"Braz J Infect Dis"},{"issue":"6","key":"4305_CR24","doi-asserted-by":"publisher","first-page":"703","DOI":"10.1097\/00002030-200104130-00005","volume":"15","author":"A Carr","year":"2001","unstructured":"Carr A, Miller J, Eisman JA, Cooper DA (2001) Osteopenia in HIV-infected men: association with asymptomatic lactic acidemia and lower weight pre-antiretroviral therapy. AIDS 15(6):703\u2013709. \nhttps:\/\/doi.org\/10.1097\/00002030-200104130-00005","journal-title":"AIDS"},{"issue":"1","key":"4305_CR25","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1016\/j.bone.2013.07.019","volume":"57","author":"EG Menezes Barbosa de","year":"2013","unstructured":"de Menezes Barbosa EG et al (2013) Impact of antiretroviral therapy on bone metabolism markers in HIV-seropositive patients. Bone 57(1):62\u201367. \nhttps:\/\/doi.org\/10.1016\/j.bone.2013.07.019","journal-title":"Bone"},{"issue":"4","key":"4305_CR26","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1007\/s10067-005-0028-x","volume":"25","author":"AM Garcia Aparicio","year":"2006","unstructured":"Garcia Aparicio AM et al (2006) Abnormalities in the bone mineral metabolism in HIV-infected patients. Clin Rheumatol 25(4):537\u2013539. \nhttps:\/\/doi.org\/10.1007\/s10067-005-0028-x","journal-title":"Clin Rheumatol"},{"issue":"1","key":"4305_CR27","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1016\/j.maturitas.2009.10.009","volume":"65","author":"A Libois","year":"2010","unstructured":"Libois A, Clumeck N, Kabeya K, Gerard M, de Wit S, Poll B, Tondeur M, Rozenberg S (2010) Risk factors of osteopenia in HIV-infected women: no role of antiretroviral therapy. Maturitas 65(1):51\u201354. \nhttps:\/\/doi.org\/10.1016\/j.maturitas.2009.10.009","journal-title":"Maturitas"},{"issue":"21\u201322","key":"4305_CR28","doi-asserted-by":"publisher","first-page":"639","DOI":"10.1007\/s00508-007-0844-x","volume":"119","author":"J Tomazic","year":"2007","unstructured":"Tomazic J et al (2007) Prevalence and risk factors for osteopenia\/osteoporosis in an HIV-infected male population. Wien Klin Wochenschr 119(21\u201322):639\u2013646. \nhttps:\/\/doi.org\/10.1007\/s00508-007-0844-x","journal-title":"Wien Klin Wochenschr"},{"issue":"11","key":"4305_CR29","doi-asserted-by":"publisher","first-page":"1746","DOI":"10.1086\/644785","volume":"200","author":"A Calmy","year":"2009","unstructured":"Calmy A, Fux CA, Norris R, Vallier N, Delhumeau C, Samaras K, Hesse K, Hirschel B, Cooper DA, Carr A (2009) Low bone mineral density, renal dysfunction, and fracture risk in HIV infection: a cross-sectional study. J Infect Dis 200(11):1746\u20131754. \nhttps:\/\/doi.org\/10.1086\/644785","journal-title":"J Infect Dis"},{"issue":"5","key":"4305_CR30","doi-asserted-by":"publisher","first-page":"643","DOI":"10.1111\/j.1365-2265.2011.04274.x","volume":"76","author":"MJ Bolland","year":"2012","unstructured":"Bolland MJ, Grey A, Horne AM, Briggs SE, Thomas MG, Ellis-Pegler RB, Gamble GD, Reid IR (2012) Stable bone mineral density over 6 years in HIV-infected men treated with highly active antiretroviral therapy (HAART). Clin Endocrinol 76(5):643\u2013648. \nhttps:\/\/doi.org\/10.1111\/j.1365-2265.2011.04274.x","journal-title":"Clin Endocrinol"},{"issue":"8","key":"4305_CR31","doi-asserted-by":"publisher","first-page":"2938","DOI":"10.1210\/jc.2006-0127","volume":"91","author":"SE Dolan","year":"2006","unstructured":"Dolan SE, Kanter JR, Grinspoon S (2006) Longitudinal analysis of bone density in human immunodeficiency virus-infected women. J Clin Endocrinol Metab 91(8):2938\u20132945. \nhttps:\/\/doi.org\/10.1210\/jc.2006-0127","journal-title":"J Clin Endocrinol Metab"},{"issue":"293","key":"4305_CR32","first-page":"1","volume":"13","author":"E Bonnet","year":"2013","unstructured":"Bonnet E et al (2013) Early loss of bone mineral density is correlated with a gain of fat mass in patients starting a protease inhibitor containing regimen: the prospective Lipotrip study. BMC Infect Dis 13(293):1\u201310","journal-title":"BMC Infect Dis"},{"issue":"3","key":"4305_CR33","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1111\/j.1468-1293.2010.00864.x","volume":"12","author":"AB Hansen","year":"2011","unstructured":"Hansen AB, Obel N, Nielsen H, Pedersen C, Gerstoft J (2011) Bone mineral density changes in protease inhibitor-sparing vs. nucleoside reverse transcriptase inhibitor-sparing highly active antiretroviral therapy: data from a randomized trial. HIV Medicine 12(3):157\u2013165. \nhttps:\/\/doi.org\/10.1111\/j.1468-1293.2010.00864.x","journal-title":"HIV Medicine"},{"issue":"4","key":"4305_CR34","doi-asserted-by":"publisher","first-page":"482","DOI":"10.1086\/367569","volume":"36","author":"K Mondy","year":"2003","unstructured":"Mondy K, Yarasheski K, Powderly WG, Whyte M, Claxton S, DeMarco D, Hoffmann M, Tebas P (2003) Longitudinal evolution of bone mineral density and bone markers in human immunodeficiency virus-infected individuals. Clin Infect Dis 36(4):482\u2013490. \nhttps:\/\/doi.org\/10.1086\/367569","journal-title":"Clin Infect Dis"},{"issue":"2","key":"4305_CR35","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1001\/jama.292.2.191","volume":"292","author":"JE Gallant","year":"2004","unstructured":"Gallant JE, Staszewski S, Pozniak AL, DeJesus E, Suleiman JM, Miller MD, Coakley DF, Lu B, Toole JJ, Cheng AK, 903 Study Group et al (2004) Efficacy and safety of tenofovir DF vs stavudine in combination therapy in antiretroviral-naive patients: a 3-year randomized trial. J Am Med Assoc 292(2):191\u2013201. \nhttps:\/\/doi.org\/10.1001\/jama.292.2.191","journal-title":"J Am Med Assoc"},{"issue":"6","key":"4305_CR36","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1371\/journal.pone.0038377","volume":"7","author":"H Haskelberg","year":"2012","unstructured":"Haskelberg H et al (2012) Changes in bone turnover and bone loss in HIV-infected patients changing treatment to tenofovir-emtricitabine or abacavir-lamivudine. PLoS One 7(6):1\u20139","journal-title":"PLoS One"},{"issue":"48","key":"4305_CR37","doi-asserted-by":"publisher","first-page":"48251","DOI":"10.1074\/jbc.M304676200","volume":"278","author":"JM Fakruddin","year":"2003","unstructured":"Fakruddin JM, Laurence J (2003) HIV envelope gp120-mediated regulation of osteoclastogenesis via receptor activator of nuclear factor kappa B ligand (RANKL) secretion and its modulation by certain HIV protease inhibitors through interferon-gamma\/RANKL cross-talk. J Biol Chem 278(48):48251\u201348258. \nhttps:\/\/doi.org\/10.1074\/jbc.M304676200","journal-title":"J Biol Chem"},{"issue":"6","key":"4305_CR38","doi-asserted-by":"publisher","first-page":"807","DOI":"10.1097\/00002030-200104130-00022","volume":"15","author":"H Knobel","year":"2001","unstructured":"Knobel H, Guelar A, Vallecillo G, Nogu\u00e9s X, D\u00edez A (2001) Osteopenia in HIV-infected patients: is it the disease or is it the treatment? AIDS 15(6):807\u2013808. \nhttps:\/\/doi.org\/10.1097\/00002030-200104130-00022","journal-title":"AIDS"},{"issue":"11","key":"4305_CR39","doi-asserted-by":"publisher","first-page":"1345","DOI":"10.1007\/s00198-005-1845-0","volume":"16","author":"M Yin","year":"2005","unstructured":"Yin M, Dobkin J, Brudney K, Becker C, Zadel JL, Manandhar M, Addesso V, Shane E (2005) Bone mass and mineral metabolism in HIV plus postmenopausal women. Osteoporos Int 16(11):1345\u20131352. \nhttps:\/\/doi.org\/10.1007\/s00198-005-1845-0","journal-title":"Osteoporos Int"},{"issue":"1","key":"4305_CR40","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1097\/QCO.0b013e32835ba6b1","volume":"26","author":"F Nakagawa","year":"2013","unstructured":"Nakagawa F, May M, Phillips A (2013) Life expectancy living with HIV: recent estimates and future implications. Curr Opin Infect Dis 26(1):17\u201325. \nhttps:\/\/doi.org\/10.1097\/QCO.0b013e32835ba6b1","journal-title":"Curr Opin Infect Dis"},{"key":"4305_CR41","doi-asserted-by":"crossref","unstructured":"Taylor A, Rogers M HIV treatments and the skeleton: do NRTIs directly effect bone cells? Bone 46:S56","DOI":"10.1016\/j.bone.2010.01.131"},{"issue":"6","key":"4305_CR42","doi-asserted-by":"publisher","first-page":"608","DOI":"10.1089\/0889222041217482","volume":"20","author":"G Pan","year":"2004","unstructured":"Pan G, Wu X, McKenna MA, Feng X, Nagy TR, McDonald JM (2004) AZT enhances osteoclastogenesis and bone loss. AIDS Res Hum Retrovir 20(6):608\u2013620. \nhttps:\/\/doi.org\/10.1089\/0889222041217482","journal-title":"AIDS Res Hum Retrovir"},{"issue":"60","key":"4305_CR43","first-page":"385","volume":"11","author":"I Ofotokun","year":"2011","unstructured":"Ofotokun I, Weitzmann MN (2011) HIV and bone metabolism. Discov Med 11(60):385\u2013393","journal-title":"Discov Med"},{"issue":"2","key":"4305_CR44","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1172\/JCI15797","volume":"114","author":"MW Wang","year":"2004","unstructured":"Wang MW et al (2004) The HIV protease inhibitor ritonavir blocks osteoclastogenesis and function by impairing RANKL-induced signaling. J Clin Invest 114(2):206\u2013213. \nhttps:\/\/doi.org\/10.1172\/JCI15797","journal-title":"J Clin Invest"},{"issue":"Suppl 3","key":"4305_CR45","doi-asserted-by":"publisher","first-page":"S391","DOI":"10.1093\/infdis\/jis199","volume":"205","author":"V Walker Harris","year":"2012","unstructured":"Walker Harris V, Brown TT (2012) Bone loss in the HIV-infected patient: evidence, clinical implications, and treatment strategies. J Infect Dis 205(Suppl 3):S391\u2013S398. \nhttps:\/\/doi.org\/10.1093\/infdis\/jis199","journal-title":"J Infect Dis"},{"issue":"1","key":"4305_CR46","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1186\/1471-2288-11-160","volume":"11","author":"J Davey","year":"2011","unstructured":"Davey J, Turner RM, Clarke MJ, Higgins JPT (2011) Characteristics of meta-analyses and their component studies in the Cochrane database of systematic reviews: a cross-sectional, descriptive analysis. BMC Med Res Methodol 11(1):160. \nhttps:\/\/doi.org\/10.1186\/1471-2288-11-160","journal-title":"BMC Med Res Methodol"},{"issue":"3","key":"4305_CR47","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1016\/j.rcl.2010.02.014","volume":"48","author":"BL Clarke","year":"2010","unstructured":"Clarke BL, Khosla S (2010) Physiology of bone loss. Radiol Clin N Am 48(3):483\u2013495. \nhttps:\/\/doi.org\/10.1016\/j.rcl.2010.02.014","journal-title":"Radiol Clin N Am"},{"issue":"8","key":"4305_CR48","doi-asserted-by":"publisher","first-page":"1242","DOI":"10.1093\/cid\/civ010","volume":"60","author":"TT Brown","year":"2015","unstructured":"Brown TT, Hoy J, Borderi M, Guaraldi G, Renjifo B, Vescini F, Yin MT, Powderly WG (2015) Recommendations for evaluation and management of bone disease in HIV. Clin Infect Dis 60(8):1242\u20131251. \nhttps:\/\/doi.org\/10.1093\/cid\/civ010","journal-title":"Clin Infect Dis"},{"issue":"2","key":"4305_CR49","doi-asserted-by":"publisher","first-page":"50","DOI":"10.11599\/germs.2016.1089","volume":"6","author":"C-E Chi\u0163u-Ti\u0219u","year":"2016","unstructured":"Chi\u0163u-Ti\u0219u C-E, Barbu EC, Laz\u0103r M, Ion DA, B\u0103d\u0103r\u0103u IA (2016) Low bone mineral density and associated risk factors in HIV-infected patients. Germs 6(2):50\u201359. \n10.11599\/germs.2016.1089","journal-title":"Germs"},{"issue":"2","key":"4305_CR50","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1097\/QAI.0b013e318289bb7e","volume":"63","author":"KM Erlandson","year":"2013","unstructured":"Erlandson KM, Allshouse AA, Jankowski CM, MaWhinney S, Kohrt WM, Campbell TB (2013) Functional impairment is associated with low bone and muscle mass among persons aging with HIV-infection. J Acquired Immune Deficiency Syndromes (1999) 63(2):209\u2013215. \nhttps:\/\/doi.org\/10.1097\/QAI.0b013e318289bb7e","journal-title":"J Acquired Immune Deficiency Syndromes (1999)"},{"issue":"1","key":"4305_CR51","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1146\/annurev.nutr.012809.104655","volume":"32","author":"SA Shapses","year":"2012","unstructured":"Shapses SA, Sukumar D (2012) Bone metabolism in obesity and weight loss. Annu Rev Nutr 32(1):287\u2013309. \nhttps:\/\/doi.org\/10.1146\/annurev.nutr.012809.104655","journal-title":"Annu Rev Nutr"},{"issue":"3","key":"4305_CR52","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1038\/nrendo.2010.199","volume":"7","author":"CG Fiorenza","year":"2011","unstructured":"Fiorenza CG, Chou SH, Mantzoros CS (2011) Lipodystrophy: pathophysiology and advances in treatment. Nat Rev Endocrinol 7(3):137\u2013150. \nhttps:\/\/doi.org\/10.1038\/nrendo.2010.199","journal-title":"Nat Rev Endocrinol"},{"issue":"10","key":"4305_CR53","doi-asserted-by":"publisher","first-page":"1483","DOI":"10.1093\/cid\/cit538","volume":"57","author":"PM Grant","year":"2013","unstructured":"Grant PM, Kitch D, McComsey GA, Dube MP, Haubrich R, Huang J, Riddler S, Tebas P, Zolopa AR, Collier AC, Brown TT (2013) Low baseline CD4+ count is associated with greater bone mineral density loss after antiretroviral therapy initiation. Clin Infect Dis 57(10):1483\u20131488. \nhttps:\/\/doi.org\/10.1093\/cid\/cit538","journal-title":"Clin Infect Dis"},{"issue":"9","key":"4305_CR54","doi-asserted-by":"publisher","first-page":"1265","DOI":"10.1097\/00002030-200206140-00009","volume":"16","author":"JS Huang","year":"2002","unstructured":"Huang JS, Mulkern RV, Grinspoon S (2002) Reduced intravertebral bone marrow fat in HIV-infected men. AIDS 16(9):1265\u20131269. \nhttps:\/\/doi.org\/10.1097\/00002030-200206140-00009","journal-title":"AIDS"}],"container-title":["Osteoporosis International"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00198-017-4305-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00198-017-4305-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00198-017-4305-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,3,3]],"date-time":"2018-03-03T02:53:00Z","timestamp":1520045580000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00198-017-4305-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,11,20]]},"references-count":54,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2018,3]]}},"alternative-id":["4305"],"URL":"https:\/\/doi.org\/10.1007\/s00198-017-4305-8","relation":{},"ISSN":["0937-941X","1433-2965"],"issn-type":[{"value":"0937-941X","type":"print"},{"value":"1433-2965","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,11,20]]}}}